RETA + TIRZ 30 MG + 30 MG

### High-Potency Multi-Incretin Receptor Co-Formulation

RETA + TIRZ (30 MG + 30 MG) delivers a massive 60 MG total peptide mass combining Retatrutide (triple agonist) and Tirzepatide (dual GIP/GLP-1 agonist) in a single co-lyophilized research matrix.

Engineered specifically for comparative receptor saturation, competitive binding affinity, and synergistic metabolic kinetics across GLP-1, GIP, and glucagon receptor complexes.

### Investigational Scope

• **Receptor Competitive Binding**: Studies competitive displacement and allosteric modulation between dual and triple incretin analogs.

• **Insulinotropic Kinetics**: Evaluates pancreatic beta-cell cAMP signaling dynamics under varying glucose concentrations.

• **Lipid Metabolism**: Observes glucagon-mediated hepatic lipid clearance alongside GIP/GLP-1 insulin-sensitizing actions.

### Specifications

• **Components**: 30 MG Retatrutide + 30 MG Tirzepatide (60 MG Total)

• **Purity**: ?99.0% (Combined HPLC profile)

• **Physical Form**: White Lyophilized Cake

• **Packaging**: Sterile Type I Borosilicate Glass Vial

### Storage & Handling

• Store unopened at -20??C in the dark.

• Reconstitute using 2-3 mL of sterile Bacteriostatic Water. Store solution at 2??C to 8??C. Do not freeze.